Home/Filings/4/0001493152-26-002879
4//SEC Filing

Seizinger Bernd R. 4

Accession 0001493152-26-002879

CIK 0001129928other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:30 PM ET

Size

5.2 KB

Accession

0001493152-26-002879

Insider Transaction Report

Form 4
Period: 2026-01-16
Transactions
  • Purchase

    Common Shares

    [F1]
    2026-01-16$1.04/sh+100,000$103,770466,991 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0294 to $1.0499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Signature
/s/ Kirk Look, Attorney-in-Fact|2026-01-20

Documents

1 file

Issuer

ONCOLYTICS BIOTECH INC

CIK 0001129928

Entity typeother

Related Parties

1
  • filerCIK 0001789042

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:30 PM ET
Size
5.2 KB